Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Proceedings

Open Access

Multidimension cultivation analysis by standard and omics methods for optimization of therapeutics production

  • Julia Gettmann1,
  • Christina Timmermann1,
  • Jennifer Becker1,
  • Tobias Thüte1,
  • Oliver Rupp2,
  • Heino Büntemeyer1,
  • Anica Lohmeier1,
  • Alexander Goesmann2 and
  • Thomas Noll1, 3Email author
Contributed equally
BMC Proceedings20137(Suppl 6):P5

https://doi.org/10.1186/1753-6561-7-S6-P5

Published: 4 December 2013

Background

During the last decades Chinese Hamster Ovary (CHO) cells have been extensively used for research and biotechnological applications. About 40% of newly approved glycosylated protein pharmaceuticals are produced in CHO cells today [1]. Despite the increasing relevance of these cells for biopharmaceutical production little is known about effects of intracellular processes on productivity and product quality.

In the last years supplementation of serum-free media with insulin - more and more replaced by IGF-1 and its analogue LongR3 - was utilized to enhance product titer and quality. To compare the intracellular effects of these two supplements an antibody producing CHO cell line was cultivated in batch mode using insulin, LongR3 or no growth factor as reference. Subsequently, different omics-techniques were applied to analyze medium and cell samples.

Materials and methods

CHO cells producing an antibody were cultured in chemically defined serum-free medium TC-BN.CHO (Teutocell AG) with addition of 6 mM glutamine. Three cultivations (37°C, pH 7.1, 40% DO, 120 rpm) were performed in 2l-bioreactor systems with supplementation of 10 mg/l insulin or 0.1 mg/l LongR3. The third culture was untreated and served as reference. Samples were taken every 24 h.

Viable cell density and cell viability were measured using Cedex (Roche). Glucose and lactate were determined via YSI 2300 STAT Plus™ Glucose & Lactate Analyzer (YSI Life Science). Quantitation of antibody production was determined using POROS® A columns (Invitrogen). N-Glycan abundance was analyzed by HPAEC-PAD method [2].

For RNA samples 'Total RNA NucleoSpin Kit' (Macherey-Nagel) was used. Quality and quantity of RNA were determined using Nano Drop 1000 (Peqlab) and Bioanalyzer (Agilent).

An in-house developed customized cDNA microarray with 41,304 probes was applied for transcriptome analysis. RNA was labeled using Agilent LIQUA Kit, one-color. Processing of microarray data was performed in ArrayLims and EMMA2 [3]. Raw data were standardized using Feature Extractor (Agilent) and LOWESS normalization.

Results

Cultivation data illustrated that maximal cell density was higher in cultivations with insulin and LongR3 compared to that without growth factor. Additionally, glucose consumption and lactate production was slightly higher in cultivations with these supplements but time point of glutamine depletion was similar in all reactors after similar cultivation time (Figure 1A). Furthermore, product quantity and product quality was not influenced by growth factor addition. The most abundant glycoforms after 7 days of cultivation were G0F with about 50% and G1F with about 40% in all cultivation set-ups (Table 1).
Figure 1

(A) Time chart of viable cell density (VCD), cell viability (CV) and extracellular metabolites [glucose (Glc), lactate (Lac), glutamine (Gln)]. (B) Number of significantly up- and down-regulated genes on day 5 in selected pathways (compared to day 3).

Table 1

N-Glycan abundance [%] after 7 days of cultivation.

Culture

G0F

G0

G1F

G1

G2F

G2

Reference

51,8

4,1

35,6

0,9

7,4

0,2

Insulin

50,6

3,4

38,6

0,9

6,3

0,2

LongR 3

52,5

1,4

38,5

0,5

6,9

0,3

For transcriptome analysis samples on day 5 were compared with those on day 3. Therefore, the following settings were used in statistical tests: a two-sample t-test with a p-value ≤ 0.01, signal intensity ≥ 6 (for A1 or A2) and intensity ratio ≥ 0.6 or ≤ -0.6 (for M1 or M2). Transcriptome data showed that LongR3 supplementation resulted in the highest transcription change (1259 up- and 1689 down-regulated). Insulin supplementation resulted in second highest transcriptomic change (1026 up- and 1404 down-regulated) and reference cultivation led to lowest changes (344 up- and 301down-regulated). Supplemented cultures showed a higher transcription change in the selected pathways, like pentose phosphate pathway, TCA and glycolysis, than the reference culture, too. In LongR3 containing cultures even more genes from these pathways were higher changed (Figure 1B).

Conclusions

Data on cell growth and productivity as well as omics results were brought together to achieve a deeper insight into cellular processes and their influence on productivity and product quality.

Cultivation data showed faster growth, glucose consumption and lactate formation for cultivations with insulin and LongR3 compared to reference culture. However, antibody titer and glycan profiles were almost similar in all cultures. This indicates that supplementation with insulin or LongR3 does not have an enhancing effect on product quality and quantity in antibody production with our CHO-K1 cells.

Additionally, transcriptome data showed that growth factor supplementation resulted in a higher transcription change than in reference cultivation. Thus, for more understanding of the influence of insulin or LongR3 supplementation on cultured CHO cells, further analysis of pathway regulation with full details is required.

Notes

Declarations

Acknowledgements

The project is co-funded by the European Union (European Regional Development Fund - Investing in your future) and the German federal state North Rhine-Westphalia (NRW).

Authors’ Affiliations

(1)
Institute of Cell Culture Technology, Bielefeld University
(2)
Bioinformatics Resource Facility, Center for Biotechnology (CeBiTec), Bielefeld University
(3)
Center for Biotechnology (CeBiTec), Bielefeld University

References

  1. Higgins E: Carbohydrate analysis throughout the development of a protein therapeutic. Glycoconj J. 2010, 2: 211-225.View ArticleGoogle Scholar
  2. Behan JL, Smith KD: The analysis of glycosylation: a continued need for high pH anion exchange chromatography. Biomed Chromatogr. 2011, 25: 39-46.View ArticlePubMedGoogle Scholar
  3. Dondrup M, Albaum SP, Griebel T, Henckel K, Junemann S, Kahlke T, Kleindt CK, Kuster H, Linke B, Mertens D, Mittard-Runte V, Neuweger H, Runte KJ, Tauch A, Tille F, Puhler A, Goesmann A: EMMA 2--a MAGE-compliant system for the collaborative analysis and integration of microarray data. BMC Bioinformatics. 2009, 10: 50-PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

© Gettmann et al.; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement